This device has been authorized by FDA under an emergency use authorization (EUA) for use by patients who are being mechanically ventilated or for treatment of obstructive sleep apnea (OSA) in spontaneously breathing patients weighing over 30kg (66 lbs) for use in the home, hospital, or institutional environment.
Features
- This device has been authorized by FDA under an emergency use authorization (EUA) for use by patients who are being mechanically ventilated or for treatment of obstructive sleep apnea (OSA) in spontaneously breathing patients weighing over 30kg (66 lbs) for use in the home, hospital, or institutional environment.
- The FDA definition of an authorized emergency use device is a device authorized by the FDA under an emergency use authorization that is used during an emergency to diagnose, treat, or prevent a serious or life-threatening disease or condition caused by a chemical, biological, radiological, or nuclear (CBRN) agent when there are no adequate, approved, and available alternatives.
- The Intended Use of the iBreeze PAP system is to deliver positive airway pressure therapy for the treatment of Obstructive Sleep Apnea (OSA) in spontaneously breathing patients weighing over 30kg (66 lbs) for use in the home, hospital, or institutional environment.
- 2-Year Limited Warranty
- For more information on the EUA, visit https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/emergency-use-authorizations-medical-devices#ucm644599
- For facts about COVID-19, visit https://www.fda.gov/media/136424/download
- For information regarding the iBreeze, please call 877-324-6599 or 516-998-4600.
Specifications
| UPC | 30092237346571 |